Overview
Fistula of the vagina to the small intestine, often referred to as a rectovaginal or enterovaginal fistula, is a complex and debilitating condition characterized by an abnormal connection between the vaginal canal and the small intestine. This condition predominantly affects women, frequently resulting from obstetric trauma, such as prolonged labor or obstetric anal sphincter injuries, though it can also arise from inflammatory bowel disease, radiation therapy, or iatrogenic causes like surgery. The clinical significance lies in its profound impact on quality of life, leading to chronic incontinence, recurrent infections, and significant psychological distress. Early and accurate diagnosis and management are crucial in day-to-day practice to prevent long-term complications and improve patient outcomes. 9Pathophysiology
The development of a vaginal-small intestine fistula typically stems from severe tissue damage and necrosis, often initiated by prolonged pressure or trauma during childbirth. This trauma disrupts the integrity of the pelvic floor structures, including the vaginal wall and adjacent bowel segments. At a cellular level, ischemia and subsequent reperfusion injury trigger an inflammatory cascade involving cytokines and chemokines, which exacerbate tissue damage and promote the formation of granulation tissue. Over time, this granulation tissue can coalesce and form an epithelialized tract connecting the vagina to the small intestine. Molecular pathways involving matrix metalloproteinases (MMPs) and their inhibitors play a critical role in tissue remodeling, potentially facilitating the abnormal connection. Additionally, chronic inflammation can lead to persistent fistulous tracts due to ongoing tissue breakdown and repair processes. 19Epidemiology
The incidence of vaginal-small intestine fistulas is relatively rare but varies geographically and is influenced by obstetric practices and healthcare quality. In regions with higher rates of obstructed labor and inadequate obstetric care, the prevalence can be notably higher. Age and obstetric history are significant risk factors, with women of reproductive age being most commonly affected. Specific geographic trends highlight higher incidences in low-resource settings where access to timely obstetric care is limited. Over time, improvements in obstetric care have led to a decrease in obstetric-related fistulas, though they remain a concern in certain populations. 9Clinical Presentation
Patients typically present with symptoms such as recurrent vaginal discharge, often foul-smelling and containing fecal material, chronic pelvic pain, and varying degrees of fecal incontinence. Other common manifestations include dyspareunia (painful intercourse), urinary symptoms like incontinence or recurrent urinary tract infections, and systemic signs of malnutrition due to chronic malabsorption. Red-flag features include significant weight loss, anemia, and signs of sepsis, which necessitate urgent medical attention. Early recognition of these symptoms is crucial for timely intervention and to prevent complications. 19Diagnosis
The diagnostic approach for a vaginal-small intestine fistula involves a combination of clinical assessment, imaging, and sometimes endoscopic evaluation.Management
Initial Management
Surgical Intervention
Postoperative Care
Refractory Cases
Complications
Prognosis & Follow-up
The prognosis for vaginal-small intestine fistulas varies based on the timeliness and effectiveness of intervention. Successful closure rates can range from 70% to 90% with appropriate surgical techniques and postoperative care. Prognostic indicators include the duration of symptoms, presence of infection, and the complexity of the fistula tract. Regular follow-up intervals typically include:Special Populations
Key Recommendations
References
1 Lapmanee S, Bunwatcharaphansakun P, Phongsupa W, Namdee K, Suttisintong K, Asawapirom U et al.. Transfersomal delivery of . Drug delivery 2025. link 2 Stelmar J, Smith SM, Lee G, Zaliznyak M, Garcia MM. Shallow-depth vaginoplasty: preoperative goals, postoperative satisfaction, and why shallow-depth vaginoplasty should be offered as a standard feminizing genital gender-affirming surgery option. The journal of sexual medicine 2023. link 3 Kim SW, Lee WM, Kim JT, Kim YH. Vulvar and vaginal reconstruction using the "angel wing" perforator-based island flap. Gynecologic oncology 2015. link 4 Dorin RP, Atala A, Defilippo RE. Bioengineering a vaginal replacement using a small biopsy of autologous tissue. Seminars in reproductive medicine 2011. link 5 Tham NL, Pan WR, Rozen WM, Carey MP, Taylor GI, Corlett RJ et al.. The pudendal thigh flap for vaginal reconstruction: optimising flap survival. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2010. link 6 Zhao M, Li P, Li S, Li Q. Use of autologous micromucosa graft for vaginoplasty in vaginal agenesis. Annals of plastic surgery 2009. link 7 Baytekin C, Menderes A, Mola F, Balik O, Tayfur V, Vayvada H. Total vaginal reconstruction with combined 'Split Labia Minora Flaps' and full-thickness skin grafts. The journal of obstetrics and gynaecology research 2007. link 8 Chen HC, Chana JS, Feng GM. A new method for vaginal reconstruction using a pedicled jejunal flap. Annals of plastic surgery 2003. link 9 Kight JR. In rural Virginia, world-class medicine: John Peter Mettauer, 1787-1878. Virginia medical 1989. link